Overexpression of HMGA2 in bladder cancer and its association with clinicopathologic features and prognosis: HMGA2 as a prognostic marker of bladder cancer

European Journal of Surgical Oncology

Volumn 37, Issue 3, 2011, Pages 265-271

  Yang, G L ^a   Zhang, L H ^a   Bo, J J ^a   Hou, K L ^a   Cai, X ^a   Chen, Y Y ^b   Li, H ^b   Liu, D M ^a   Huang, Y R ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Bladder cancer; HMGA2; Prognosis

Indexed keywords

HIGH MOBILITY GROUP A2 PROTEIN; MESSENGER RNA;

ADULT; ARTICLE; BLADDER CANCER; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UROTHELIUM; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CHI-SQUARE DISTRIBUTION; FEMALE; HMGA2 PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 79851514944     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2011.01.004     Document Type: Article

References (25)

1. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2009 CA Cancer J Clin 59 4 2009 225 249
2. W. Zhang, Y.B. Xiang, and Z.W. Liu Trends analysis of common urologic neoplasm incidence of elderly people in Shanghai, 1973-1999 Ai Zheng 23 5 2004 555 558
3. R. Reeves, and L. Beckerbauer HMGI/Y proteins: flexible regulators of transcription and chromatin structure Biochim Biophys Acta 1519 1-2 2001 13 29 (Pubitemid 32530787)
4. A. Fusco, and M. Fedele Roles of HMGA proteins in cancer Nat Rev Cancer 7 12 2007 899 910 (Pubitemid 350165857)
5. I. Cleynen, and W.J. Van de Ven The HMGA proteins: a myriad of functions Int J Oncol 32 2 2008 289 305
6. R. Reeves Molecular biology of HMGA proteins: hubs of nuclear function Gene 277 1-2 2001 63 81 (Pubitemid 32972109)
7. G. Chiappetta, A. Bandiera, and M.T. Berlingieri The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias Oncogene 10 7 1995 1307 1314
8. P. Rogalla, K. Drechsler, and G. Frey HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors Am J Pathol 149 3 1996 775 779 (Pubitemid 26334162)
9. U. Hirning-Folz, M. Wilda, and V. Rippe The expression pattern of the Hmgic gene during development Genes Chromosomes Cancer 23 4 1998 350 357 (Pubitemid 28507375)
10. P. Rogalla, K. Drechsler, and B. Kazmierczak Expression of HMGI-C, a member of the high mobility group protein family, in a subset of breast cancers: relationship to histologic grade Mol Carcinog 19 3 1997 153 156 (Pubitemid 27360132)
11. V.K. Sarhadi, H. Wikman, and K. Salmenkivi Increased expression of high mobility group A proteins in lung cancer J Pathol 209 2 2006 206 212 (Pubitemid 43805416)
12. B. Meyer, S. Loeschke, and A. Schultze HMGA2 overexpression in non-small cell lung cancer Mol Carcinog 46 7 2007 503 511 (Pubitemid 47068069)
13. N. Abe, T. Watanabe, and Y. Suzuki An increased high-mobility group A2 expression level is associated with malignant phenotype in pancreatic exocrine tissue Br J Cancer 89 11 2003 2104 2109 (Pubitemid 38030910)
14. J. Miyazawa, A. Mitoro, and S. Kawashiri Expression of mesenchyme-specific gene HMGA2 in squamous cell carcinomas of the oral cavity Cancer Res 64 6 2004 2024 2029 (Pubitemid 38339449)
15. G. Belge, A. Meyer, and M. Klemke Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias Genes Chromosomes Cancer 47 1 2008 56 63 (Pubitemid 350191464)
16. C. Langelotz, P. Schmid, and C. Jakob Expression of high-mobility-group- protein HMGI-C mRNA in the peripheral blood is an independent poor prognostic indicator for survival in metastatic breast cancer Br J Cancer 88 9 2003 1406 1410 (Pubitemid 36606424)
17. M.W. Pfaffl A new mathematical model for relative quantification in real-time RT-PCR Nucleic Acids Res 29 9 2001 May 1 2002 2007
18. K. Motoyama, H. Inoue, and Y. Nakamura Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family Clin Cancer Res 14 8 2008 2334 2340 (Pubitemid 351551065)
19. P. Angel, and M. Karin The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation Biochim Biophys Acta 1072 2-3 1991 129 157 (Pubitemid 121007534)
20. M. Karin, Z. Liu, and E. Zandi AP-1 function and regulation Curr Opin Cell Biol 9 2 1997 240 246 (Pubitemid 27135992)
21. M.A. Huber, N. Kraut, and H. Beug Molecular requirements for epithelial-mesenchymal transition during tumor progression Curr Opin Cell Biol 17 5 2005 548 558 (Pubitemid 41267170)
22. S. Thuault, U. Valcourt, and M. Petersen Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition J Cell Biol 174 2 2006 175 183 (Pubitemid 44079853)
23. S. Watanabe, Y. Ueda, and S. Akaboshi HMGA2 maintains oncogenic RAS-induced epithelial-mesenchymal transition in human pancreatic cancer cells Am J Pathol 174 3 2009 854 868
24. A.R. Young, and M. Narita Oncogenic HMGA2: short or small? Genes Dev 21 9 2007 1005 1009 (Pubitemid 46686469)
25. S. Shell, S.M. Park, and A.R. Radjabi Let-7 expression defines two differentiation stages of cancer Proc Natl Acad Sci U S A 104 27 2007 11400 11405 (Pubitemid 47175152)